首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2681652篇
  免费   240426篇
  国内免费   13710篇
耳鼻咽喉   37104篇
儿科学   83634篇
妇产科学   66719篇
基础医学   451760篇
口腔科学   70638篇
临床医学   238969篇
内科学   454324篇
皮肤病学   80187篇
神经病学   237071篇
特种医学   108340篇
外国民族医学   58篇
外科学   422520篇
综合类   83505篇
现状与发展   26篇
一般理论   2049篇
预防医学   223474篇
眼科学   61191篇
药学   182821篇
  21篇
中国医学   9410篇
肿瘤学   121967篇
  2022年   24047篇
  2021年   57495篇
  2020年   36103篇
  2019年   59386篇
  2018年   71298篇
  2017年   53868篇
  2016年   60239篇
  2015年   76324篇
  2014年   110842篇
  2013年   176408篇
  2012年   78190篇
  2011年   73984篇
  2010年   114268篇
  2009年   120083篇
  2008年   58671篇
  2007年   58163篇
  2006年   69658篇
  2005年   65160篇
  2004年   66838篇
  2003年   57873篇
  2002年   47574篇
  2001年   60727篇
  2000年   51582篇
  1999年   60141篇
  1998年   60601篇
  1997年   59659篇
  1996年   57233篇
  1995年   52751篇
  1994年   46916篇
  1993年   43977篇
  1992年   38157篇
  1991年   35635篇
  1990年   33023篇
  1989年   33260篇
  1988年   30997篇
  1987年   30154篇
  1986年   28660篇
  1985年   30017篇
  1984年   32293篇
  1983年   30934篇
  1982年   36106篇
  1981年   34580篇
  1980年   32673篇
  1979年   24609篇
  1978年   25520篇
  1977年   24359篇
  1976年   21998篇
  1975年   19750篇
  1974年   18336篇
  1973年   17525篇
排序方式: 共有10000条查询结果,搜索用时 93 毫秒
61.
62.
63.
64.
65.
Major depressive disorder and other neuropsychiatric disorders are often managed with long-term use of antidepressant medication. Fluoxetine, an SSRI antidepressant, is widely used as a first-line treatment for neuropsychiatric disorders. However, fluoxetine has also been shown to increase the risk of metabolic diseases such as non-alcoholic fatty liver disease. Fluoxetine has been shown to increase hepatic lipid accumulation in vivo and in vitro. In addition, fluoxetine has been shown to alter the production of prostaglandins which have also been implicated in the development of non-alcoholic fatty liver disease. The goal of this study was to assess the effect of fluoxetine exposure on the prostaglandin biosynthetic pathway and lipid accumulation in a hepatic cell line (H4-II-E-C3 cells). Fluoxetine treatment increased mRNA expression of prostaglandin biosynthetic enzymes (Ptgs1, Ptgs2, and Ptgds), PPAR gamma (Pparg), and PPAR gamma downstream targets involved in fatty acid uptake (Cd36, Fatp2, and Fatp5) as well as production of 15-deoxy-Δ12,14PGJ2 a PPAR gamma ligand. The effects of fluoxetine to induce lipid accumulation were attenuated with a PTGS1 specific inhibitor (SC-560), whereas inhibition of PTGS2 had no effect. Moreover, SC-560 attenuated 15-deoxy-Δ12,14PGJ2 production and expression of PPAR gamma downstream target genes. Taken together these results suggest that fluoxetine-induced lipid abnormalities appear to be mediated via PTGS1 and its downstream product 15d-PGJ2 and suggest a novel therapeutic target to prevent some of the adverse effects of fluoxetine treatment.  相似文献   
66.
Cognitive Therapy and Research - Despite interest in psychological inflexibility as a marker of suicide risk, no measure of psychological inflexibility specific to SI exists. The present study...  相似文献   
67.
68.
69.
70.
Gestational trophoblastic neoplasia (GTN) patients are treated according to the eight-variable International Federation of Gynaecology and Obstetrics (FIGO) scoring system, that aims to predict first-line single-agent chemotherapy resistance. FIGO is imperfect with one-third of low-risk patients developing disease resistance to first-line single-agent chemotherapy. We aimed to generate simplified models that improve upon FIGO. Logistic regression (LR) and multilayer perceptron (MLP) modelling (n = 4191) generated six models (M1-6). M1, all eight FIGO variables (scored data); M2, all eight FIGO variables (scored and raw data); M3, nonimaging variables (scored data); M4, nonimaging variables (scored and raw data); M5, imaging variables (scored data); and M6, pretreatment hCG (raw data) + imaging variables (scored data). Performance was compared to FIGO using true and false positive rates, positive and negative predictive values, diagnostic odds ratio, receiver operating characteristic (ROC) curves, Bland-Altman calibration plots, decision curve analysis and contingency tables. M1-6 were calibrated and outperformed FIGO on true positive rate and positive predictive value. Using LR and MLP, M1, M2 and M4 generated small improvements to the ROC curve and decision curve analysis. M3, M5 and M6 matched FIGO or performed less well. Compared to FIGO, most (excluding LR M4 and MLP M5) had significant discordance in patient classification (McNemar's test P < .05); 55-112 undertreated, 46-206 overtreated. Statistical modelling yielded only small gains over FIGO performance, arising through recategorisation of treatment-resistant patients, with a significant proportion of under/overtreatment as the available data have been used a priori to allocate primary chemotherapy. Streamlining FIGO should now be the focus.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号